Search - tctmd.com

Displaying 1 - 20 of 902

Sort: Relevancy | Date

News Daily News

Smartwatch Increases AF Diagnosis in Older, High-risk Patients: EQUAL

Todd Neale

January 23, 2026

News Opinion Conversations in Cardiology

What Counts as a PCI Complication? That Can Be Hard to Pin Down

January 02, 2026

News Daily News

Frailty Extra Risky in Young Patients With Acute MI

Caitlin E. Cox

December 04, 2025

News Conference News AHA 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Michael O'Riordan

November 12, 2025

News Conference News TCT 2025

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

Todd Neale

October 28, 2025

Presentation TCT 2025

TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials

Presenter: Yousif Ahmad

October 28, 2025

Presentation TCT 2025

ACS (high risk NSTEMI) with use of Cangrelor

Presenter: Evan Shlofmitz

October 28, 2025

Presentation TCT 2025

TCT 68: Early Initiation of PCSK9 Inhibitors in Acute STEMI: Safety and Efficacy Outcomes from the EARLY-STEMI Trial

Presenter: Mohammed Ali

October 28, 2025

Presentation TCT 2025

TCT 66: Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 65: Colchicine for Post-Myocardial Infarction Management: A Systematic Review and Meta-Analysis

Presenter: Aqeel Khanani

October 28, 2025

Presentation TCT 2025

TCT 1952: Medisattva Is a Mobile Application, (First of Its Kind in the World) Which Prevents Medical Prescription Errors

Presenter: Krishnakishore Goyal

October 28, 2025

Presentation TCT 2025

TCT 60: Acute-phase Lipid-lowering Effects of Evolocumab in Patients with AMI; Pre-specified Secondary Analysis of the EVO-STEMI Trial

Presenter: Hyun-Jong Lee

October 28, 2025

Presentation TCT 2025

TCT 59: Evolocumab in Patients with Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

Presenter: Jinying Zhou

October 28, 2025

Presentation TCT 2025

When and How Should I Use Physiologic Indices in Patients with STEMI or NSTEMI

Presenter: Kayla Chiew

October 28, 2025

Presentation TCT 2025

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

Presenter: Claudio Laudani

October 28, 2025

Presentation TCT 2025

TCT 63: Clinical Outcomes of Early Versus Late DAPT Initiation in NSTEACS: A Propensity-Matched TriNetX Cohort Study

Presenter: Muhammad U. Khan

October 28, 2025

Presentation TCT 2025

TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention

Presenter: Khaled Elnaggar

October 28, 2025

Presentation TCT 2025

TCT 1639: Zero-Contrast Multivessel PCI in a NSTEMI Patient With Heart Failure and Renal Insufficiency Accompanied by Brain Metastasis of Thyroid Cancer

Presenter: Xiao Wang

October 28, 2025

Presentation TCT 2025

TCT 1209: Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Non-ST-segment elevation Acute Coronary Syndrome: An Updated Meta-analysis.

Presenter: Khaled Elnaggar

October 27, 2025

Presentation TCT 2025

TCT 1211: Understanding the Burden of Schizophrenia on Adults Admitted with NSTEMI in the United States

Presenter: Piyush Puri

October 27, 2025

Advertisement

Smartwatch Increases AF Diagnosis in Older, High-risk Patients: EQUAL

What Counts as a PCI Complication? That Can Be Hard to Pin Down

Frailty Extra Risky in Young Patients With Acute MI

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

PROCTOR: PCI of Failed Bypass Grafts Tops Native-Vessel PCI, With Caveats

TCT 69: Optimal P2Y12 inhibitor strategy after acute coronary syndrome: a network meta-analysis of randomised controlled trials

ACS (high risk NSTEMI) with use of Cangrelor

TCT 68: Early Initiation of PCSK9 Inhibitors in Acute STEMI: Safety and Efficacy Outcomes from the EARLY-STEMI Trial

TCT 66: Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial

TCT 65: Colchicine for Post-Myocardial Infarction Management: A Systematic Review and Meta-Analysis

TCT 1952: Medisattva Is a Mobile Application, (First of Its Kind in the World) Which Prevents Medical Prescription Errors

TCT 60: Acute-phase Lipid-lowering Effects of Evolocumab in Patients with AMI; Pre-specified Secondary Analysis of the EVO-STEMI Trial

TCT 59: Evolocumab in Patients with Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation

When and How Should I Use Physiologic Indices in Patients with STEMI or NSTEMI

TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry.

TCT 63: Clinical Outcomes of Early Versus Late DAPT Initiation in NSTEACS: A Propensity-Matched TriNetX Cohort Study

TCT 61: Comparative Analysis of Composite Outcomes for Double vs Triple Therapy in Patients with Atrial Fibrillation Post Percutaneous Coronary Intervention

TCT 1639: Zero-Contrast Multivessel PCI in a NSTEMI Patient With Heart Failure and Renal Insufficiency Accompanied by Brain Metastasis of Thyroid Cancer

TCT 1209: Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Non-ST-segment elevation Acute Coronary Syndrome: An Updated Meta-analysis.

TCT 1211: Understanding the Burden of Schizophrenia on Adults Admitted with NSTEMI in the United States

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content